Maternal cfDNA screening for Down syndrome – a cost sensitivity analysis
作者： Howard Cuckle , Peter Benn , Eugene Pergament
DOI: 10.1002/PD.4157
关键词: Obstetrics 、 Ultrasonography 、 Unit cost 、 Activity-based costing 、 Medicine 、 Down syndrome 、 Detection rate 、 Combined test 、 Marginal cost 、 Cost–benefit analysis
摘要: Objective This study aimed to determine the principal factors contributing to the cost of avoiding a birth with Down syndrome by using cell‐free DNA (cfDNA) to replace conventional …
sci-hub.se 参考文章(19)
Howard S. Cuckle, Peter A. Benn, Multi‐Marker Maternal Serum Screening for Chromosomal Abnormalities John Wiley & Sons, Ltd. pp. 771- 818 ,(2010) , 10.1002/9781444314342.CH24
Howard Cuckle, David Aitken, Sandra Goodburn, Brian Senior, Kevin Spencer, Sue Standing, UK National Down's Syndrome Screening Programme, Laboratory Advisory Group, Age-standardisation when target setting and auditing performance of Down syndrome screening programmes. Prenatal Diagnosis. ,vol. 24, pp. 851- 856 ,(2004) , 10.1002/PD.990
Mary E. Norton, Herb Brar, Jonathan Weiss, Ardeshir Karimi, Louise C. Laurent, Aaron B. Caughey, M. Hellen Rodriguez, John Williams, Michael E. Mitchell, Charles D. Adair, Hanmin Lee, Bo Jacobsson, Mark W. Tomlinson, Dick Oepkes, Desiree Hollemon, Andrew B. Sparks, Arnold Oliphant, Ken Song, Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18 American Journal of Obstetrics and Gynecology. ,vol. 207, pp. 137- ,(2012) , 10.1016/J.AJOG.2012.05.021
H. S. CUCKLE, N. J. WALD, S. G. THOMPSON, Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. British Journal of Obstetrics and Gynaecology. ,vol. 94, pp. 387- 402 ,(1987) , 10.1111/J.1471-0528.1987.TB03115.X
Ken Song, Thomas J. Musci, Aaron B. Caughey, Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population Journal of Maternal-fetal & Neonatal Medicine. ,vol. 26, pp. 1180- 1185 ,(2013) , 10.3109/14767058.2013.770464
Howard Cuckle, Down syndrome fetal loss rate in early pregnancy. Prenatal Diagnosis. ,vol. 19, pp. 1177- 1179 ,(1999) , 10.1002/(SICI)1097-0223(199912)19:12<1177::AID-PD714>3.0.CO;2-N
K. L. Wilson, J. L. Czerwinski, J. M. Hoskovec, S. J. Noblin, C. M. Sullivan, A. Harbison, M. W. Campion, K. Devary, P. Devers, C. N. Singletary, NSGC Practice Guideline: Prenatal Screening and Diagnostic Testing Options for Chromosome Aneuploidy Journal of Genetic Counseling. ,vol. 22, pp. 4- 15 ,(2013) , 10.1007/S10897-012-9545-3
Ghalia Ashoor, Argyro Syngelaki, Marion Wagner, Cahit Birdir, Kypros H. Nicolaides, Chromosome-selective sequencing of maternal plasma cell–free DNA for first-trimester detection of trisomy 21 and trisomy 18 American Journal of Obstetrics and Gynecology. ,vol. 206, ,(2012) , 10.1016/J.AJOG.2012.01.029
Ann Tabor, Zarko Alfirevic, Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagnosis and Therapy. ,vol. 27, pp. 1- 7 ,(2010) , 10.1159/000271995
Andrew B. Sparks, Craig A. Struble, Eric T. Wang, Ken Song, Arnold Oliphant, Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. American Journal of Obstetrics and Gynecology. ,vol. 206, pp. 3- 9 ,(2012) , 10.1016/J.AJOG.2012.01.030